Announcement
18 May 2021
In May 2021, the French government provided further financing to OSE Immunotherapeutics to develop a new COVID-19 vaccine candidate. The support was given under the France Relance framework.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
18 May 2021
Revocation date:
No revocation date
Announced: 18 May 2021
State loan
In force
On 18 May 2021, the French government provided a EUR 10.7 (approx. USD 13.1 million) loan to OSE Immunotherapeutics for financing the next stages of the development of a COVID-19 vaccine candidate. Th...
Sign in to see more
Threads
See all
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70627
interventions
194
jurisdictions
G7: Harmful Trade Policy Interventions
This Thread tracks harmful trade policy interventions introduced by G7 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 13 Jan 2025
25516
interventions
38
jurisdictions
G20: Harmful Trade Policy Interventions
This Thread tracks harmful trade policy interventions introduced by G20 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 15 Jan 2025
53959
interventions
121
jurisdictions
Harmful Trade Policy Interventions: Medical Goods
This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...
Published: 09 Jan 2025
7346
interventions
152
jurisdictions